Sanofi Tells 3rd Circ. Post-Ch. 11 Drug Sales Triggered Deal
Sales of a drug that a Mallinckrodt PLC unit bought the rights for prior to its 2020 Chapter 11 bankruptcy should still trigger an obligation to pay the drug's originator royalties,...To view the full article, register now.
Already a subscriber? Click here to view full article